Aug 16, 2022

Merck bags chance to test ADCs based on Starpharma delivery tech

"Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based on a dendrimer drug delivery platform", as featured in Fierce Pharma. Read the article here.

 This contains certain forward-looking statements.